Association of Systemic Immune Inflammation Index with All-Cause, Cardiovascular Disease, and Cancer-Related

Shengjue Xiao1, Zhenwei Wang1, Ronghua Zuo2

  • 1Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China.

Insights

The systemic immune inflammation (SII) index shows a U-shaped relationship with mortality from all causes, cardiovascular disease (CVD), and cancer in CVD patients. This indicates that both very low and very high SII index levels are associated with increased mortality risk.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Public Health

Background:

  • The systemic immune inflammation (SII) index, a marker of systemic inflammation, has been explored for its prognostic value in various diseases.
  • Understanding the association between SII index and mortality outcomes in patients with cardiovascular disease (CVD) is crucial for risk stratification and management.

Purpose of the Study:

  • To investigate the relationship between the SII index and all-cause, CVD-specific, and cancer-related mortality in a US population with diagnosed CVD.
  • To explore the nature of this association, including potential non-linear relationships.

Main Methods:

  • Utilized data from the National Health and Nutrition Examination Survey (1999-2018).
  • Employed restricted cubic splines (RCS) and Cox proportional hazard models to analyze the association between SII index and mortality outcomes.
  • Conducted subgroup analyses to examine associations in specific CVD subtypes.

Main Results:

  • A U-shaped correlation was observed between the SII index and all-cause, CVD, and cancer-related mortality in patients with CVD.
  • Compared to the lowest quartile, higher quartiles of SII index showed increased hazard ratios for all-cause, CVD, and cancer mortality.
  • Specific CVD subtypes like coronary heart disease (CHD), angina, and myocardial infarction exhibited a U-shaped relationship, while congestive heart failure (CHF) and stroke showed a positive linear correlation with CVD mortality at higher SII index levels.

Conclusions:

  • The SII index demonstrates a U-shaped association with all-cause, CVD, and cancer-related mortality in the general US population with CVD.
  • This finding suggests that both low and high levels of systemic immune inflammation may be detrimental for patients with cardiovascular disease.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
14
Inflammation01:38

Inflammation

Overview
54.3K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
133
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
18
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
42